ClinicalTrials.Veeva

Menu

Nociception-Level (NOL) for the Assessment of Pain in Patient Unable to Self-Report (MoNOLog)

M

Medasense

Status

Completed

Conditions

Unconscious
Ventilator Lung
Opioid Use
Dementia
Pain

Treatments

Device: PMD200

Study type

Observational

Funder types

Other

Identifiers

NCT04581642
CLI-01-1-09

Details and patient eligibility

About

In this study we aimed to investigate the performance and effectiveness of NOL and/or NOLedge as a tool for pain assessment in geriatric and critical ill non communicating patients.

Our hypothesis was that NOL and the NOLedge may have good correlation with the health-care professional assessment PAINAD, BPS values, even with the use of the drugs affecting autonomic nervous system.

Enrollment

33 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male and female, Age > 18 years old.
  • Spontaneously breathing or mechanically ventilated
  • Any patient who is unable to express his/her own level of personal pain by using visual scales according to the hospital standard
  • Written informed consent provided by the participant (if they have capacity) or guardian (if they do not have capacity) or a written proxy informed consent from a legally authorized representative empowered to make health-related decisions for the potential study participant.

Exclusion criteria

  • A patient whose staff or research team believes that his or her participation in the research will cause suffering to the patient.
  • Unstable condition preventing planned routine procedures of care, and conditions precluding the use of PMD-200: absence of sinus cardiac rhythm.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems